A heart patient's own skin cells soon could be used to repair damaged cardiac tissue thanks to pioneering stem cell research of the University of Houston's newest biomedical scientist, Robert Schwartz.
His new technique for reprogramming human skin cells puts him at the forefront of a revolution in medicine that could one day lead to treatments for Alzheimer's, diabetes, muscular dystrophy and many other diseases.
Schwartz brings his ground-breaking research to UH as the Cullen Distinguished Professor of Biology and Biochemistry and head of UH's new Center for Gene Regulation and Molecular Therapeutics. He also is affiliated with the Texas Heart Institute at St. Luke's Episcopal Hospital in the Texas Medical Center, where he is director of stem cell engineering.
"Professor Schwartz's work will save lives, and his decision to pursue this pioneering research at UH is a big leap forward on our way to Tier-One status," said John Bear, dean of the UH College of Natural Sciences and Mathematics. "Together with the many other outstanding scientists we've assembled here, Schwartz will help make this university a major player in medical research."
Schwartz devised a method for turning ordinary human skin cells into heart cells. The cells developed are similar to embryonic stem cells and ultimately can be made into early-stage heart cells derived from a patient's own skin. These then could be implanted and grown into fully developed beating heart cells, reversing the damage caused by previous heart attacks. These new cells would replace the damaged cardiac tissue that weakens the heart's ability to pump, develops into scar tissue and causes arrhythmias. Early clinical trials using these reprogrammed cells on actual heart patients could begin within one or two years.
Although Schwartz is not the first scientist to turn adult cells into such stem cells, his improved method could pave the way for breakthroughs in other diseases. Schwartz's method requires fewer steps and yields more stem cells. Armed with an effective way to make induced stem cells from a patient's own skin, scientists can then begin the work of growing all kinds of human cells.
For example, new brain cells could treat Alzheimer's patients or those with severe brain trauma, or a diabetic could get new insulin-producing cells in the pancreas. Generating new kidney, lung or liver tissue is also possible, with scientists even being able to one day grow an entirely new heart or other organ from these reprogrammed cells. Additionally, Schwartz and his team are working on turning induced stem cells into skeletal muscle cells to treat muscular dystrophy.
"We're trying to advance science in ways folks never even dreamed about," Schwartz said. "The idea of having your own bag of stem cells that you can carry through life and use for tissue regeneration is at the very cutting edge of science."
This latest biomedical hire is a major step in the UH Health Initiative, an effort aimed at having the university become a world-class center for medical research. Creating new cross-disciplinary academic and health-related research opportunities for faculty and students is crucial to this initiative, as are collaborations with other Texas Medical Center member institutions. One of its top goals is to increase the amount of sponsored research expenditures awarded to UH, which is a key factor in attaining Tier-One status.
"Dr. Schwartz will expand UH's expertise in promising new areas of scientific discovery to alleviate human disease. By recruiting premier scientists like Schwartz, UH is fast becoming a major player in the regional biomedical research community," said Kathryn Peek, assistant vice president of University Health Initiatives at UH.
Schwartz has decades of experience at the Texas Medical Center. Before coming to UH, he was director of the Institute of Biosciences and Technology, a research component of the Texas A&M Health Science Center. He also was a longtime tenured professor at Baylor College of Medicine and co-directed the school's Center for Cardiovascular Development. The new research center Schwartz heads at UH will be housed in state-of-the-art laboratory facilities at the university's Science and Engineering Research Center.
What attracted him to UH was the commitment of administrators and faculty to making the university a premier center for biomedical research. His hiring comes just a year after the arrival of Jan-Åke Gustafsson, a world-renowned scientist and cancer researcher. They join other leading UH faculty, ranging from biochemists to computer scientists and mathematicians, who are deeply involved in cutting-edge medical research.
About the University of Houston
The University of Houston, Texas' premier metropolitan research and teaching institution, is home to more than 40 research centers and institutes and sponsors more than 300 partnerships with corporate, civic and governmental entities. UH, the most diverse research university in the country, stands at the forefront of education, research and service with more than 37,000 students.
About the College of Natural Sciences and Mathematics
The UH College of Natural Sciences and Mathematics, with 170 ranked faculty and approximately 4,500 students, offers bachelor's, master's and doctoral degrees in the natural sciences, computational sciences and mathematics. Faculty members in the departments of biology and biochemistry, chemistry, computer science, earth and atmospheric sciences, mathematics and physics conduct internationally recognized research in collaboration with industry, Texas Medical Center institutions, NASA and others worldwide.
For more information about UH, visit the university's Newsroom at http://www.uh.edu/news-events/.
To receive UH science news via e-mail, visit http://www.uh.edu/news-events/mailing-lists/sciencelistserv.php.
For additional news alerts about UH, follow us on Facebook at http://tinyurl.com/6qw9ht and on Twitter at http://twitter.com/UH_News.
Lisa Merkl | EurekAlert!
Further reports about: > Medical Wellness > Science TV > Texas > biomedical research > brain cell > embryonic stem cell > health services > heart cells > human cell > human skin > human skin cells > insulin-producing cell > medical research > muscular dystrophy > natural science > skin cell > stem cells
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
Russian researchers together with their French colleagues discovered that a genuine feature of superconductors -- quantum Abrikosov vortices of supercurrent -- can also exist in an ordinary nonsuperconducting metal put into contact with a superconductor. The observation of these vortices provides direct evidence of induced quantum coherence. The pioneering experimental observation was supported by a first-ever numerical model that describes the induced vortices in finer detail.
These fundamental results, published in the journal Nature Communications, enable a better understanding and description of the processes occurring at the...
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
25.06.2018 | Physics and Astronomy
25.06.2018 | Earth Sciences
25.06.2018 | Power and Electrical Engineering